Long-chain n-3 fatty acid levels in baseline serum phospholipids do not predict later occurrence of depressive episodes: A nested case-control study within a cohort of middle-aged French men and women

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 81, Issue 4, 2009, Pages 265-271

  Astorg, Pierre ^a   Bertrais, Sandrine ^b   Alessandri, Jean Marc ^a   Guesnet, Philippe ^a   Kesse Guyot, Emmanuelle ^b   Linard, Alain ^a   Lallemand, Marie Sylvie ^a   Galan, Pilar ^b   Hercberg, Serge ^b  

^a INRA   (France)

^b Unité de Recherches Mesures Physiques Métrologie   (France)

Author keywords

Cohort; Depression; Long chain n 3 PUFA; Serum fatty acids

Indexed keywords

ANTIDEPRESSANT AGENT; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LONG CHAIN FATTY ACID; OMEGA 3 FATTY ACID; PHOSPHOLIPID;

ADULT; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; FAT INTAKE; FATTY ACID BLOOD LEVEL; FEMALE; FRANCE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PHOSPHOLIPID BLOOD LEVEL; POPULATION BASED CASE CONTROL STUDY; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT;

EID: 70349628446     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2009.06.002     Document Type: Article

References (43)

1. Freeman M.P., Hibbeln J.R., Wisner K.L., Davis J.M., Mischoulon D., Peet M., Keck Jr. P.E., Marangell L.B., Richardson A.J., Lake J., and Stoll A.L. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J. Clin. Psychiatry 67 (2006) 1954-1967
2. McNamara R.K., and Carlson S.E. Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins Leukot. Essent. Fatty Acids 75 (2006) 329-349
3. Parker G., Gibson N.A., Brotchie H., Heruc G., Rees A.M., and Hadzi-Pavlovic D. Omega-3 fatty acids and mood disorders. Am. J. Psychiatry 163 (2006) 969-978
4. Adams P.B., Lawson S., Sanigorski A., and Sinclair A.J. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 31 Suppl (1996) S157-S161
5. Edwards R., Peet M., Shay J., and Horrobin D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J. Affect. Disord. 48 (1998) 149-155
6. Appleton K.M., Hayward R.C., Gunnell D., Peters T.J., Rogers P.J., Kessler D., and Ness A.R. Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials. Am. J. Clin. Nutr. 84 (2006) 1308-1316
7. Lin P.Y., and Su K.P. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J. Clin. Psychiatry 68 (2007) 1056-1061
8. Jazayeri S., Tehrani-Doost M., Keshavarz S.A., Hosseini M., Djazayery A., Amini H., Jalali M., and Peet M. Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder. Aust. N.Z. J. Psychiatry 42 (2008) 192-198
9. Nemets H., Nemets B., Apter A., Bracha Z., and Belmaker R.H. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am. J. Psychiatry 163 (2006) 1098-1100
10. Barberger-Gateau P., Jutand M.A., Letenneur L., Larrieu S., Tavernier B., and Berr C. Correlates of regular fish consumption in French elderly community dwellers: data from the Three-City study. Eur. J. Clin. Nutr. 59 (2005) 817-825
11. Mamalakis G., Tornaritis M., and Kafatos A. Depression and adipose essential polyunsaturated fatty acids. Prostaglandins Leukot. Essent. Fatty Acids 67 (2002) 311-318
12. Raeder M.B., Steen V.M., Vollset S.E., and Bjelland I. Associations between cod liver oil use and symptoms of depression: The Hordaland Health Study. J. Affect. Disord. 101 (2006) 245-249
13. Tanskanen A., Hibbeln J.R., Hintikka J., Haatainen K., Honkalampi K., and Viinamaki H. Fish consumption, depression, and suicidality in a general population. Arch. Gen. Psychiatry 58 (2001) 512-513
14. Tanskanen A., Hibbeln J.R., Tuomilehto J., Uutela A., Haukkala A., Viinamaki H., Lehtonen J., and Vartiainen E. Fish consumption and depressive symptoms in the general population in Finland. Psychiatr. Serv. 52 (2001) 529-531
15. Tiemeier H., Tuijl H.R., Hofman A., Kiliaan A.J., and Breteler M.M. Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study. Am. J. Clin. Nutr. 78 (2003) 40-46
16. Timonen M., Horrobin D., Jokelainen J., Laitinen J., Herva A., and Räsänen P. Fish consumption and depression : the Northern Finland 1966 birth cohort study. J Affect. Disord. 82 (2004) 447-452
17. Astorg P., Couthouis A., Bertrais S., Arnault N., Meneton P., Guesnet P., Alessandri J.M., Galan P., and Hercberg S. Association of fish and long-chain n-3 polyunsaturated fatty acid intakes with the occurrence of depressive episodes in middle-aged French men and women. Prostaglandins Leukot. Essent. Fatty Acids 78 (2008) 171-182
18. Hercberg S., Galan P., Preziosi P., Bertrais S., Mennen L., Malvy D., Roussel A.M., Favier A., and Briancon S. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch. Intern. Med 164 (2004) 2335-2342
19. Hercberg S., Preziosi P., Briancon S., Galan P., Triol I., Malvy D., Roussel A.M., and Favier A. A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study-design, methods, and participant characteristics. SUpplementation en VItamines et Mineraux AntioXydants. Control Clin. Trials 19 (1998) 336-351
20. Astorg P., Couthouis A., Courcy G.P., Bertrais S., Arnault N., Meneton P., Galan P., and Hercberg S. Association of folate intake with the occurrence of depressive episodes in middle-aged French men and women. Br. J. Nutr. 100 (2008) 183-187
21. Alessandri J.M., Poumes-Ballihaut C., Langelier B., Perruchot M.H., Raguenez G., Lavialle M., and Guesnet P. Incorporation of docosahexaenoic acid into nerve membrane phospholipids: bridging the gap between animals and cultured cells. Am. J. Clin. Nutr. 78 (2003) 702-710
22. Juaneda P., and Rocquelin G. Rapid and convenient separation of phospholipids and non phosphorus lipids from rat heart using silica cartridges. Lipids 20 (1985) 40-41
23. Kamphuis M.H., Geerlings M.I., Tijhuis M.A., Kalmijn S., Grobbee D.E., and Kromhout D. Depression and cardiovascular mortality: a role for n-3 fatty acids?. Am. J. Clin. Nutr. 84 (2006) 1513-1517
24. Conklin S.M., Manuck S.B., Yao J.K., Flory J.D., Hibbeln J.R., and Muldoon M.F. High omega-6 and low omega-3 fatty acids are associated with depressive symptoms and neuroticism. Psychosom. Med. 69 (2007) 932-934
25. Feart C., Peuchant E., Letenneur L., Samieri C., Montagnier D., Fourrier-Reglat A., and Barberger-Gateau P. Plasma eicosapentaenoic acid is inversely associated with severity of depressive symptomatology in the elderly: data from the Bordeaux sample of the Three-City Study. Am. J. Clin. Nutr. 87 (2008) 1156-1162
26. Parker G.B., Heruc G.A., Hilton T.M., Olley A., Brotchie H., Hadzi-Pavlovic D., Friend C., Walsh W.F., and Stocker R. Low levels of docosahexaenoic acid identified in acute coronary syndrome patients with depression. Psychiatry Res. 141 (2006) 279-286
27. Amin A.A., Menon R.A., Reid K.J., Harris W.S., and Spertus J.A. Acute coronary syndrome patients with depression have low blood cell membrane omega-3 fatty acid levels. Psychosom. Med. 70 (2008) 856-862
28. Mamalakis G., Kiriakakis M., Tsibinos G., Hatzis C., Flouri S., Mantzoros C., and Kafatos A. Depression and serum adiponectin and adipose omega-3 and omega-6 fatty acids in adolescents. Pharmacol. Biochem. Behav. 85 (2006) 474-479
29. Mamalakis G., Kalogeropoulos N., Andrikopoulos N., Hatzis C., Kromhout D., Moschandreas J., and Kafatos A. Depression and long chain n-3 fatty acids in adipose tissue in adults from Crete. Eur. J. Clin. Nutr 60 (2006) 882-888
30. Sarri K.O., Linardakis M., Tzanakis N., and Kafatos A.G. Adipose DHA inversely associated with depression as measured by the Beck Depression Inventory. Prostaglandins Leukot. Essent. Fatty Acids 78 (2008) 117-122
31. Appleton K.M., Gunnell D., Peters T.J., Ness A.R., Kessler D., and Rogers P.J. No clear evidence of an association between plasma concentrations of n-3 long-chain polyunsaturated fatty acids and depressed mood in a non-clinical population. Prostaglandins Leukot. Essent. Fatty Acids 78 (2008) 337-342
32. Mamalakis G., Jansen E., Cremers H., Kiriakakis M., Tsibinos G., and Kafatos A. Depression and adipose and serum cholesteryl ester polyunsaturated fatty acids in the survivors of the seven countries study population of Crete. Eur. J. Clin. Nutr. 60 (2006) 1016-1023
33. Mamalakis G., Kiriakakis M., Tsibinos G., Jansen E., Cremers H., Strien C., Hatzis C., Moschandreas J., Linardakis M., Kromhout D., and Kafatos A. Lack of an association of depression with n-3 polyunsaturated fatty acids in adipose tissue and serum phospholipids in healthy adults. Pharmacol. Biochem. Behav. 89 (2008) 6-10
34. Sublette M.E., Hibbeln J.R., Galfalvy H., Oquendo M.A., and Mann J.J. Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk. Am. J. Psychiatry 163 (2006) 1100-1102
35. Hakkarainen R., Partonen T., Haukka J., Virtamo J., Albanes D., and Lonnqvist J. Is low dietary intake of omega-3 fatty acids associated with depression?. Am. J. Psychiatry 161 (2004) 567-569
36. Almeida O.P., Norman P., Hankey G., Jamrozik K., and Flicker L. Successful mental health aging: results from a longitudinal study of older Australian men. Am. J. Geriatr. Psychiatry 14 (2006) 27-35
37. Astorg P., Bertrais S., Laporte F., Arnault N., Estaquio C., Galan P., Favier A., and Hercberg S. Plasma n-6 and n-3 polyunsaturated fatty acids as biomarkers of their dietary intakes: a cross-sectional study within a cohort of middle-aged French men and women. Eur. J. Clin. Nutr. 62 (2008) 1155-1161
38. Raison C.L., Capuron L., and Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends. Immunol. 27 (2006) 24-31
39. Sarandol A., Sarandol E., Eker S.S., Erdinc S., Vatansever E., and Kirli S. Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. Hum. Psychopharmacol. 22 (2007) 67-73
40. Serhan C.N. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu. Rev. Immunol. 25 (2007) 101-137
41. Song C., Zhang X.Y., and Manku M. Increased phospholipase A2 activity and inflammatory response but decreased nerve growth factor expression in the olfactory bulbectomized rat model of depression: effects of chronic ethyl-eicosapentaenoate treatment. J. Neurosci. 29 (2009) 14-22
42. Appleton K.M., Woodside J.V., Yarnell J.W., Arveiler D., Haas B., Amouyel P., Montaye M., Ferrieres J., Ruidavets J.B., Ducimetiere P., Bingham A., and Evans A. Depressed mood and dietary fish intake: Direct relationship or indirect relationship as a result of diet and lifestyle?. J. Affect. Disord. 104 (2007) 217-223
43. Cohen B.E., Garg S.K., Ali S., Harris W.S., and Whooley M.A. Red blood cell docosahexaenoic acid and eicosapentaenoic acid concentrations are positively associated with socioeconomic status in patients with established coronary artery disease: data from the Heart and Soul Study. J. Nutr. 138 (2008) 1135-1140